Stock Events

Stock Events

Atea Pharmaceuticals (AVIR) Q1 2026 Earnings

5MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.57

-0.51

-0.46

-0.4

Details

Expected EPS

-0.485

Actual EPS

-0.57

Surprise EPS

-0.08

Surprise Percent

+17.53%

Description

Atea Pharmaceuticals (AVIR) has reported earnings of -0.57 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.